Human IGF-I Recombinant Protein, PeproTech
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0448473-V3
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $249.69
About this award
Life Technologies Corporation has been awarded contract A207_PO-0448473-V3 by the University of Virginia on August 8, 2026, for the supply of Human Insulin-like Growth Factor I (IGF-I) Recombinant Protein manufactured by PeproTech. The contract encompasses 249 units at a unit price of $1 each, for a total contract value of $249. The contracting organization is the University of Virginia, located in Virginia.
The line item specifies delivery of the Human IGF-I Recombinant Protein to the designated buyer. This recombinant protein product is commonly utilized in research and biotechnology applications within academic and institutional settings. The award represents a straightforward procurement transaction for laboratory reagents to support the University of Virginia's operational and research requirements.
Line items
| Item | Total |
|---|---|
| Human IGF-I Recombinant Protein, PeproTech | $249.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0448473-V3?
Contract A207_PO-0448473-V3 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 8, 2026.
How much is contract A207_PO-0448473-V3 worth?
Its cumulative value is $249.69.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award